Patients who have recently had orthopedic and other types of general surgery, those who have recently had a stroke, and those with an ongoing medical condition (such as heart disease) are at most risk for developing venous thromboembolic disease. Do most long-term care facilities screen for this condition among these patient populations, and when should physicians initiate prophylactic care? Dr. Laurie Jacobs, professor of clinical medicine and vice chairman of clinical and educational programs in the department of medicine at Albert Einstein College of Medicine and Montefiore Medical Center, and director of the Resnick Gerontology Center at Albert Einstein College of Medicine in Bronx, New York, discusses ways to reduce the risk of developing venous thromboembolism among long-term care patients. What is on the horizon in terms of new therapies? Hosted by Dr. Eric Tangalos.
Screening and Prophylaxis for Venous Thromboembolism

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Patients who have recently had orthopedic and other types of general surgery, those who have recently had a stroke, and those with an ongoing medical condition (such as heart disease) are at most risk for developing venous thromboembolic disease. Do most long-term care facilities screen for this condition among these patient populations, and when should physicians initiate prophylactic care? Dr. Laurie Jacobs, professor of clinical medicine and vice chairman of clinical and educational programs in the department of medicine at Albert Einstein College of Medicine and Montefiore Medical Center, and director of the Resnick Gerontology Center at Albert Einstein College of Medicine in Bronx, New York, discusses ways to reduce the risk of developing venous thromboembolism among long-term care patients. What is on the horizon in terms of new therapies? Hosted by Dr. Eric Tangalos.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Love Story: Lipid Education for Women’s Heart Health
Navigating Myasthenia Gravis in Adolescents and Young Adults
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?